289 related articles for article (PubMed ID: 25981617)
1. Influence of glioma cells on a new co-culture in vitro blood-brain barrier model for characterization and validation of permeability.
Mendes B; Marques C; Carvalho I; Costa P; Martins S; Ferreira D; Sarmento B
Int J Pharm; 2015 Jul; 490(1-2):94-101. PubMed ID: 25981617
[TBL] [Abstract][Full Text] [Related]
2. In vivo measurement of glioma-induced vascular permeability.
Lee J; Baird A; Eliceiri BP
Methods Mol Biol; 2011; 763():417-22. PubMed ID: 21874468
[TBL] [Abstract][Full Text] [Related]
3. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier.
Watson PM; Paterson JC; Thom G; Ginman U; Lundquist S; Webster CI
BMC Neurosci; 2013 Jun; 14():59. PubMed ID: 23773766
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an in vitro coculture model for the blood-brain barrier: comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources.
Scism JL; Laska DA; Horn JW; Gimple JL; Pratt SE; Shepard RL; Dantzig AH; Wrighton SA
In Vitro Cell Dev Biol Anim; 1999; 35(10):580-92. PubMed ID: 10614867
[TBL] [Abstract][Full Text] [Related]
5. Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier.
Walter FR; Veszelka S; Pásztói M; Péterfi ZA; Tóth A; Rákhely G; Cervenak L; Ábrahám CS; Deli MA
J Neurochem; 2015 Sep; 134(6):1040-54. PubMed ID: 26112237
[TBL] [Abstract][Full Text] [Related]
6. Involvement of DMT1 +IRE in the transport of lead in an in vitro BBB model.
Wang Q; Luo W; Zhang W; Liu M; Song H; Chen J
Toxicol In Vitro; 2011 Jun; 25(4):991-8. PubMed ID: 19913089
[TBL] [Abstract][Full Text] [Related]
7. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
8. Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood-brain barrier.
Hurst RD; Fritz IB
J Cell Physiol; 1996 Apr; 167(1):81-8. PubMed ID: 8698844
[TBL] [Abstract][Full Text] [Related]
9. Development of an in vitro blood-brain barrier model based on immortalized porcine brain microvascular endothelial cells.
Lauer R; Bauer R; Linz B; Pittner F; Peschek GA; Ecker G; Friedl P; Noe CR
Farmaco; 2004 Feb; 59(2):133-7. PubMed ID: 14871505
[TBL] [Abstract][Full Text] [Related]
10. The role of extracellular-5'-nucleotidase/CD73 in glioma peritumoural brain edema.
Wang B; Wang D; Zhu Z; Wang W; Zhang X; Tang F; Zhou Y; Wang H; Liu M; Yao X; Yan X
Neurol Sci; 2016 Apr; 37(4):603-11. PubMed ID: 26884147
[TBL] [Abstract][Full Text] [Related]
11. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
[TBL] [Abstract][Full Text] [Related]
12. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide.
Boveri M; Kinsner A; Berezowski V; Lenfant AM; Draing C; Cecchelli R; Dehouck MP; Hartung T; Prieto P; Bal-Price A
Neuroscience; 2006; 137(4):1193-209. PubMed ID: 16343789
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
14. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
[TBL] [Abstract][Full Text] [Related]
15. Identification of neuronal and angiogenic growth factors in an in vitro blood-brain barrier model system: Relevance in barrier integrity and tight junction formation and complexity.
Freese C; Hanada S; Fallier-Becker P; Kirkpatrick CJ; Unger RE
Microvasc Res; 2017 May; 111():1-11. PubMed ID: 27988246
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
17. Co-culture based blood-brain barrier in vitro model, a tissue engineering approach using immortalized cell lines for drug transport study.
Zhang Z; McGoron AJ; Crumpler ET; Li CZ
Appl Biochem Biotechnol; 2011 Jan; 163(2):278-95. PubMed ID: 20652765
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model.
Labus J; Häckel S; Lucka L; Danker K
J Neurosci Methods; 2014 May; 228():35-45. PubMed ID: 24631939
[TBL] [Abstract][Full Text] [Related]
19. VEGF receptor-1 involvement in pericyte loss induced by Escherichia coli in an in vitro model of blood brain barrier.
Salmeri M; Motta C; Anfuso CD; Amodeo A; Scalia M; Toscano MA; Alberghina M; Lupo G
Cell Microbiol; 2013 Aug; 15(8):1367-84. PubMed ID: 23421875
[TBL] [Abstract][Full Text] [Related]
20. Murine in vitro model of the blood-brain barrier for evaluating drug transport.
Shayan G; Choi YS; Shusta EV; Shuler ML; Lee KH
Eur J Pharm Sci; 2011 Jan; 42(1-2):148-55. PubMed ID: 21078386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
